TherapeuticsMD TXMD
NASDAQ TXMD
$1.90 +0.02 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) EV to EBITDA (2022 - 2023)

Updated

TherapeuticsMD's EV to EBITDA came in at 0.52 for Q3 2023, down 48.9% from the prior quarter.

Analysis

TherapeuticsMD (TXMD) EV to EBITDA (2022 - 2023) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, TherapeuticsMD reported EV to EBITDA of -1.39; for FY2022, it was 1.58.

  • Business Quant data shows TXMD's EV to EBITDA at 1.01 (Q2 2023), 1.07 (Q1 2023) and 1.58 (Q4 2022) in the three quarters before Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 TherapeuticsMD 21.67 Mn 21.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 0.52
Jun 30, 2023 1.01
Mar 31, 2023 1.07
Dec 31, 2022 1.58
API Access

TherapeuticsMD EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TXMD&period=max&api_key=YOUR_API_KEY